LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 159 of 166
Next
>>
>
3951 to 3975 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Mean Relative Cell Count	Standard Error of the Mean for Relative Cell Count	Mean Normalized Growth Rate Inhibition Value	Standard Error of the Mean for Normalized Growth Rate Inhibition Value
MCF 10A	GSK1904529A	0.37	uM	LJP6	0.5451	0.1632	0.6565	0.1252
MCF 10A	GSK1904529A	1.11	uM	LJP6	0.5004	0.1630	0.6083	0.1360
MCF 10A	GSK1904529A	3.33	uM	LJP6	0.5111	0.1609	0.6213	0.1303
MCF 10A	GSK1904529A	10	uM	LJP6	0.5131	0.1360	0.6339	0.1032
MCF 10A	Linsitinib	0.04	uM	LJP5	0.9210	0.0626	0.9556	0.0316
MCF 10A	Linsitinib	0.12	uM	LJP5	0.8506	0.0891	0.9107	0.0468
MCF 10A	Linsitinib	0.37	uM	LJP5	0.7325	0.1552	0.8241	0.0947
MCF 10A	Linsitinib	1.11	uM	LJP5	0.6818	0.1593	0.7835	0.1021
MCF 10A	Linsitinib	3.33	uM	LJP5	0.6243	0.1689	0.7307	0.1180
MCF 10A	Linsitinib	10	uM	LJP5	0.5262	0.1816	0.6259	0.1495
MCF 10A	Ruxolitinib	0.04	uM	LJP5	0.9671	0.0122	0.9818	0.0047
MCF 10A	Ruxolitinib	0.12	uM	LJP5	0.9807	0.0091	0.9898	0.0041
MCF 10A	Ruxolitinib	0.37	uM	LJP5	0.9591	0.0164	0.9778	0.0064
MCF 10A	Ruxolitinib	1.11	uM	LJP5	0.9210	0.0286	0.9557	0.0110
MCF 10A	Ruxolitinib	3.33	uM	LJP5	0.9083	0.0317	0.9482	0.0123
MCF 10A	Ruxolitinib	10	uM	LJP5	0.7278	0.0572	0.8279	0.0225
MCF 10A	Momelotinib	0.04	uM	LJP5	0.9279	0.0313	0.9593	0.0135
MCF 10A	Momelotinib	0.12	uM	LJP5	0.8698	0.0452	0.9242	0.0186
MCF 10A	Momelotinib	0.37	uM	LJP5	0.7853	0.0562	0.8684	0.0221
MCF 10A	Momelotinib	1.11	uM	LJP5	0.6878	0.0696	0.7993	0.0270
MCF 10A	Momelotinib	3.33	uM	LJP5	0.5141	0.0962	0.6491	0.0599
MCF 10A	Momelotinib	10	uM	LJP5	0.1706	0.0364	0.1850	0.0625
MCF 10A	Fedratinib	0.04	uM	LJP5	0.9818	0.0187	0.9894	0.0112
MCF 10A	Fedratinib	0.12	uM	LJP5	0.9396	0.0176	0.9637	0.0107
MCF 10A	Fedratinib	0.37	uM	LJP5	0.8983	0.0258	0.9382	0.0162

|<
<<
Previous
Page 159 of 166
Next
>>
>
3951 to 3975 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 14 of 15: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20251)